查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1936967

全球猪疫苗市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Swine Vaccines Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 227 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计猪疫苗市场规模将从 2025 年的 22.8 亿美元成长到 2034 年的 36.9 亿美元，2026 年至 2034 年的复合年增长率预计为 5.49%。

受猪群感染疾病日益普遍的推动，猪隻疫苗市场预计将呈现强劲成长。随着全球猪肉需求持续攀升，确保猪群健康和生产力的有效疫苗接种策略至关重要。新病原体的出现和先前已控制的疾病的復发，都要求疫苗製剂的研发必须持续进行。各公司正大力投资于创新技术，例如重组疫苗和mRNA疫苗，这些技术有望提高疫苗的有效性和安全性，从而应对养猪户面临的不断变化的挑战。

此外，畜牧养殖户生物安全意识的提高对猪隻疫苗市场产生了显着影响。养殖户越来越认识到疫苗接种作为综合畜群管理策略的关键要素的重要性。这种意识的转变推动了疾病预防工作的积极发展，从而提高了疫苗接种率，并建构了更具抵抗力的猪群。将数位化工具应用于疫苗接种计划的监测和管理也日益普及，使养殖户能够优化畜群健康管理实践，并提高整体生产力。

此外，全球养猪业的扩张，尤其是在新兴市场，为猪隻疫苗市场带来了盈利机会。随着各国不断提升畜牧能力以满足日益增长的消费需求，实施先进的疫苗接种计画至关重要。疫苗生产商与农业组织之间的合作有望促进技术转让，并改善这些地区取得疫苗技术的途径。猪疫苗市场前景广阔，其特点是技术持续创新、疾病防治意识提升以及为改善动物健康和福利所做的努力。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球猪疫苗市场：依产品划分

  • 市场分析、洞察与预测
  • 灭活疫苗
  • 减毒活病毒疫苗
  • 重组疫苗
  • 次单位疫苗
  • 类毒素疫苗
  • 其他产品

第五章：全球猪疫苗市场：依疾病类型划分

  • 市场分析、洞察与预测
  • 猪繁殖与呼吸综合症（PRRS）
  • 猪环状病毒2型（PCV2）
  • 霉浆菌肺炎支原体
  • 经典型猪瘟（CSF）
  • 猪流感
  • 丹毒
  • 口蹄疫
  • 非洲猪瘟（ASF）
  • 猪细小病毒
  • 其他疾病类型

第六章：全球猪疫苗市场：依最终用户划分

  • 市场分析、洞察与预测
  • 兽医医院和诊所
  • 养猪场
  • 研究机构

第七章 全球猪疫苗市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Biogenesis Bago
    • Bioveta
    • Boehringer Ingelheim International GmbH
    • Ceva SantAfA（C）Animale
    • Elanco Animal Health Incorporated
    • HIPRA
    • Indian Immunologicals Limited
    • Merck & Co. Inc
    • Phibro Animal Health Corporation
    • Vaxxinova
    • Virbac
    • Zoetis Inc
简介目录
Product Code: VMR11214069

The Swine Vaccines Market size is expected to reach USD 3.69 Billion in 2034 from USD 2.28 Billion (2025) growing at a CAGR of 5.49% during 2026-2034.

The swine vaccines market is set for robust growth, driven by the increasing prevalence of infectious diseases affecting pig populations. As the global demand for pork continues to rise, the need for effective vaccination strategies to ensure herd health and productivity becomes paramount. The emergence of novel pathogens and the resurgence of previously controlled diseases necessitate ongoing research and development in vaccine formulations. Companies are investing heavily in innovative technologies, such as recombinant vaccines and mRNA-based solutions, which promise enhanced efficacy and safety profiles, thereby addressing the evolving challenges faced by swine producers.

Moreover, the growing awareness of biosecurity measures among livestock farmers is significantly influencing the swine vaccines market. Producers are increasingly recognizing the importance of vaccination as a critical component of comprehensive herd management strategies. This shift in mindset is fostering a proactive approach to disease prevention, leading to higher vaccination rates and, consequently, a more resilient swine population. The integration of digital tools for monitoring and managing vaccination schedules is also gaining traction, enabling farmers to optimize their herd health management practices and improve overall productivity.

Additionally, the expansion of the global swine industry, particularly in emerging markets, presents lucrative opportunities for the swine vaccines market. As countries strive to enhance their livestock production capabilities to meet growing consumer demand, the adoption of advanced vaccination programs becomes essential. Collaborations between vaccine manufacturers and agricultural organizations are expected to facilitate knowledge transfer and improve access to vaccination technologies in these regions. The future of the swine vaccines market appears promising, characterized by continuous innovation, increased awareness of disease management, and a commitment to enhancing animal health and welfare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Inactivated vaccines
  • Live attenuated vaccines
  • Recombinant vaccines
  • Subunit vaccines
  • Toxoid vaccines
  • Other products

By Disease Type

  • Porcine reproductive and respiratory syndrome (PRRS)
  • Porcine circovirus type 2 (PCV2)
  • Mycoplasma hyopneumoniae
  • Classical swine fever (CSF)
  • Swine influenza
  • Erysipelas
  • Foot-and-Mouth disease (FMD)
  • African swine fever (ASF)
  • Porcine parvovirus
  • Other disease types

By End-user

  • Veterinary hospitals & clinics
  • Swine farms
  • Research institutes

COMPANIES PROFILED

  • Biogenesis Bago, Bioveta, Boehringer Ingelheim International GmbH, Ceva Sant Animale, Elanco Animal Health Incorporated, HIPRA, Indian Immunologicals Limited, Merck Co Inc, Phibro Animal Health Corporation, Vaxxinova, Virbac, Zoetis Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL SWINE VACCINES MARKET: BY PRODUCT 2022-2034 (USD MN and Million Doses)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Inactivated vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.3. Live attenuated vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.4. Recombinant vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.5. Subunit vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.6. Toxoid vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.7. Other products Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 5. GLOBAL SWINE VACCINES MARKET: BY DISEASE TYPE 2022-2034 (USD MN and Million Doses)

  • 5.1. Market Analysis, Insights and Forecast Disease Type
  • 5.2. Porcine reproductive and respiratory syndrome (PRRS) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.3. Porcine circovirus type 2 (PCV2) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.4. Mycoplasma hyopneumoniae Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.5. Classical swine fever (CSF) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.6. Swine influenza Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.7. Erysipelas Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.8. Foot-and-Mouth disease (FMD) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.9. African swine fever (ASF) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.10. Porcine parvovirus Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.11. Other disease types Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 6. GLOBAL SWINE VACCINES MARKET: BY END-USER 2022-2034 (USD MN and Million Doses)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Veterinary hospitals & clinics Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.3. Swine farms Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.4. Research institutes Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 7. GLOBAL SWINE VACCINES MARKET: BY REGION 2022-2034(USD MN and Million Doses)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.2.1 By Product
    • 7.2.2 By Disease Type
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.3.1 By Product
    • 7.3.2 By Disease Type
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.4.1 By Product
    • 7.4.2 By Disease Type
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.5.1 By Product
    • 7.5.2 By Disease Type
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.6.1 By Product
    • 7.6.2 By Disease Type
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SWINE VACCINES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Biogenesis Bago
    • 9.2.2 Bioveta
    • 9.2.3 Boehringer Ingelheim International GmbH
    • 9.2.4 Ceva SantAfA(C) Animale
    • 9.2.5 Elanco Animal Health Incorporated
    • 9.2.6 HIPRA
    • 9.2.7 Indian Immunologicals Limited
    • 9.2.8 Merck & Co. Inc
    • 9.2.9 Phibro Animal Health Corporation
    • 9.2.10 Vaxxinova
    • 9.2.11 Virbac
    • 9.2.12 Zoetis Inc